Breast Neoplasms
"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
Descriptor ID |
D001943
|
MeSH Number(s) |
C04.588.180 C17.800.090.500
|
Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Neoplasms, Breast
- Tumors, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Mammary Carcinoma, Human- Mammary Carcinoma, Human
- Carcinoma, Human Mammary
- Carcinomas, Human Mammary
- Human Mammary Carcinomas
- Mammary Carcinomas, Human
- Human Mammary Carcinoma
Breast Cancer- Breast Cancer
- Cancer, Breast
- Cancer of Breast
- Mammary Cancer
- Malignant Neoplasm of Breast
- Malignant Tumor of Breast
- Breast Carcinoma
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 2 | 0 | 2 | 1981 | 2 | 0 | 2 | 1983 | 2 | 0 | 2 | 1984 | 1 | 0 | 1 | 1985 | 3 | 0 | 3 | 1986 | 3 | 0 | 3 | 1987 | 2 | 0 | 2 | 1988 | 4 | 0 | 4 | 1989 | 1 | 1 | 2 | 1990 | 0 | 1 | 1 | 1991 | 1 | 0 | 1 | 1992 | 0 | 1 | 1 | 1993 | 5 | 0 | 5 | 1994 | 6 | 0 | 6 | 1995 | 5 | 1 | 6 | 1996 | 4 | 1 | 5 | 1997 | 2 | 0 | 2 | 1998 | 4 | 4 | 8 | 1999 | 2 | 4 | 6 | 2000 | 1 | 1 | 2 | 2001 | 5 | 2 | 7 | 2002 | 10 | 2 | 12 | 2003 | 6 | 2 | 8 | 2004 | 15 | 3 | 18 | 2005 | 18 | 1 | 19 | 2006 | 10 | 0 | 10 | 2007 | 22 | 1 | 23 | 2008 | 14 | 2 | 16 | 2009 | 14 | 1 | 15 | 2010 | 14 | 4 | 18 | 2011 | 9 | 2 | 11 | 2012 | 8 | 1 | 9 | 2013 | 10 | 2 | 12 | 2014 | 12 | 1 | 13 | 2015 | 5 | 5 | 10 | 2016 | 13 | 1 | 14 | 2017 | 14 | 6 | 20 | 2018 | 12 | 1 | 13 | 2019 | 19 | 0 | 19 | 2020 | 8 | 2 | 10 | 2021 | 10 | 0 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Yun NK, Slostad JA, Naqib A, Frankenberger C, Perez CB, Ghai R, Usha L. Histologic Discordance Between Primary Tumor and Nodal Metastasis in Breast Cancer: Solving a Clinical Conundrum in the Era of Genomics. Oncologist. 2021 12; 26(12):1000-1005.
-
Duan L, Calhoun S, Shim D, Perez RE, Blatter LA, Maki CG. Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells. J Mol Cell Biol. 2021 09 11; 13(6):433-444.
-
Deliere A, Attai D, Victorson D, Kuchta K, Pesce C, Kopkash K, Sisco M, Seth A, Yao K. Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Have the Lowest Levels of Regret: The WhySurg Study. Ann Surg Oncol. 2021 Oct; 28(10):5686-5697.
-
Sheean P, Gomez-Perez S, Joyce C, O'Connor P, Bojko M, Smith A, Vasilopoulos V, Rao R, Sclamberg J, Robinson P. Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer. Breast Cancer Res Treat. 2021 Nov; 190(1):121-132.
-
Kopkash K, Novak K, Murphy R, Deliere A, Kuchta K, Rabbitt S, Pesce C, Winchester D, Yao K. Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and Operating Room Positioning Protocol. Ann Surg Oncol. 2021 Oct; 28(10):5698-5706.
-
Okwuosa TM, Morgans A, Rhee JW, Reding KW, Maliski S, Plana JC, Volgman AS, Moseley KF, Porter CB, Ismail-Khan R. Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2021 06; 14(3):e000082.
-
Kaufman PA, Hurvitz SA, O'Shaughnessy J, Mason G, Yardley DA, Brufsky AM, Rugo HS, Cobleigh M, Swain SM, Tripathy D, Morris A, Antao V, Li H, Jahanzeb M. Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry. Breast Cancer Res Treat. 2021 Jul; 188(1):179-190.
-
Yu L, Han S, Lang L, Song H, Zhang C, Dong L, Jia S, Zhang Y, Xiao D, Liu J, Xu Y, Zhang X. Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest. Phytomedicine. 2021 Apr; 84:153504.
-
Yao KA, Attai D, Bleicher R, Kuchta K, Moran M, Boughey J, Wilke LG, Dietz JR, Stevens R, Pesce C, Kopkash K, Kurtzman S, Sarantou T, Victorson D. Covid-19 related oncologist's concerns about breast cancer treatment delays and physician well-being (the CROWN study). Breast Cancer Res Treat. 2021 Apr; 186(3):625-635.
-
Tandon M, Othman AH, Winogradzki M, Pratap J. Bone metastatic breast cancer cells display downregulation of PKC-? with enhanced glutamine metabolism. Gene. 2021 Apr 05; 775:145419.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|